Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.37
(
-1.67%
)
Bitcoin
75,662.38
(
-0.24%
)
News Focus
News Focus
Post# of 988
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

NY1972

Send PM Follow Ignore
Followers 4
Posts 1443
Boards Moderated 0
Alias Born 10/03/2015

NY1972

Re: jondoeuk post# 429

Tuesday, 10/22/2024 9:36:22 PM

Tuesday, October 22, 2024 9:36:22 PM

Post# of 988
Sounds like it is not part of novel H2CasMab-2 binder and 1XX CAR.
Selective: Uniquely exhibits robust and preferential targeting of HER2 on tumor cells and not
on normal cells, aided by novel H2CasMab-2 binder and TRAC-mediated 1XX CAR activity
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent FATE News
More FATE News